• >
  • >
  • >
  • >
  • >
Upload Avatar (500 x 500)
李红昌
Life Science
中国科学院大学
广东
Language: 中文, 英语
Contact
细胞周期 调控 机制 抗肿瘤 天然多肽 药物 纳米材料 研究 生物学 癌症
Areas of Focus
  • 细胞周期调控机制
  • 天然多肽药物抗肿瘤机制
  • 纳米材料抗肿瘤机制
Work Experience
  • 2011-11 至今 - 中国科学院深圳先进技术研究院 - 研究员
  • 2006-07 至 2010-08 - 美国普度大学生物化学系 - 博士后
Academic Background & Achievements
  • 1999-09 至 2006-06 博士: 中国科学院遗传与发育生物学研究所
  • 1995-09 至 1999-07 学士: 北京师范大学生物系
Publications
  • Bifunctional Compounds as Molecular Degraders for Integrin-facilitated Targeted Protein Degradation, Jiwei Zheng, Wanyi He, Jing Li, Hongchang Li, Liang Chen, Lijing Fang, 2023
  • A nanomaterial targeting the spike protein captures SARS-CoV-2 variants and promotes viral elimination, Guofang Zhang, Hongchang Li, Liming Wang, Yang Li, 2022
  • Cell-penetrating riboflavin conjugate for antitumor photodynamic therapy, Wu, Chunlei, Hongchang Li, Fang, Lijing, 2022
  • Intrinsic bioactivity of black phosphorus nanomaterials on mitotic centrosome destabilization through suppression of PLK1 kinase, Shao, Ximing, Ding, Zhihao, Zhou, Wenhua, Li, Yanyan, Li, Zhibin, Cui, Haodong, Lin, Xian, Cao, Guoli, Cheng, Binghua, Sun, Haiyan, Li, Meiqing, Liu, Ke, Lu, Danyi, Geng, Shengyong, Shi, Wenli, Zhang, Guofang, Song, Qingle, Chen, Liang, Wang, Guocheng, Su, Wu, Cai, Lintao, Fang, Lijing, Leong, David Tai, Li, Yang, Yu, XueFeng, Li, Hongchang, 2021
  • A Novel N-methylated Cyclodepsipeptide Prodrug for Targeted Cancer Therapy, Wu, Chunlei, Hongchang Li, Lijing Fang, 2021
  • Coibamide A kills cancer cells through inhibiting autophagy, Shi, Wenli, Lu, Danyi, Wu, Chunlei, Li, Meiqing, Ding, Zhihao, Li, Yanyan, Chen, Binghua, Lin, Xian, Su, Wu, Shao, Ximing, Xia, Zhihui, Fang, Lijing, Liu, Ke, Li, Hongchang, 2021
  • Novel N-Methylated Cyclodepsipeptide Prodrugs for Targeted Cancer Therapy, Wu, Chunlei, Cheng, Zhehong, Lu, Danyi, Liu, Ke, Cheng, Yulian, Wang, Pengxin, Zhou, Yimin, Li, Meiqing, Shao, Ximing, Li, Hongchang, Su, Wu, Fang, Lijing, 2021
  • Clinical HDAC Inhibitors Are Effective Drugs to Prevent the Entry of SARS-CoV2, Liu, Ke, Zou, Rongfeng, Cui, Wenqiang, Li, Meiqing, Wang, Xueying,
Post a Project

联系我们

欢迎与我们交流!
* Required
* Required
* Required
* Invalid email address
提交此表单,即表示您同意 Asia Growth Partners 可以与您联系并分享洞察和营销信息。
不,谢谢,我不想收到来自 Asia Growth Partners 的任何营销电子邮件。
提交

感谢您的信息!
我们会很快与你取得联系。